J. Wouter Jukema

Professor, MD, PhD, FESC, FACC

Contributions

Which patient needs the PCSK9 inhibitors most?89th EAS Congress 2021A deep look to the results of Odyssey outcomes87th EAS Congress 2019The ideal patient for PCSK986th EAS Congress 2018

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this